Everads Therapy

Everads TherapyEverads Therapy
Everads Therapy

Everads Therapy

Developing novel suprachoroidal delivery technology for targeted, rapid, and durable retinal disease treatments.

DR 312017Active10
Rate

About

Everads Therapy is an emerging startup focused on developing innovative delivery technology for retinal diseases. Their proprietary suprachoroidal delivery platform is designed to enable targeted, rapid, and durable administration of treatments directly to the choroid and retina, aiming to enhance treatment efficacy and reduce patient burden.
Frequently asked

What does Everads Therapy do?

Everads Therapy is an emerging startup focused on developing innovative delivery technology for retinal diseases. Their proprietary suprachoroidal delivery platform is designed to enable targeted, rapid, and durable administration of treatments directly to the choroid and retina, aiming to enhance treatment efficacy and reduce patient burden.

What is Everads Therapy's revenue?

StartupHub estimates Everads Therapy's annual revenue at $1.6M (range $953K to $2.7M, 64% confidence), based on comparable companies in the sector.

When was Everads Therapy founded?

Everads Therapy was founded in 2017.

What industry does Everads Therapy operate in?

Everads Therapy operates in Life Sciences, MedTech, HealthTech, Drug Discovery, Biotech, Medical Devices.

How many employees does Everads Therapy have?

Everads Therapy has approximately 10 people on record.

HEADCOUNT
10
DOMAIN RATING
31
Comments

No comments yet. Be the first to share your take.